Both in Biotechnology
CG Oncology vs Iovance Biotherapeutics
Over the past year CGON returned +80.5% and IOVA returned +548.0%; their daily moves had a correlation of 0.21.
CGON +80.5% IOVA +548.0%Growth of $1, one year, split-adjusted
| Metric | CGON | IOVA |
|---|---|---|
| Price | $70.52 | $14.45 |
| Market cap | $6.25B | $6.55B |
| Today | +1.31% | +31.48% |
| 1 month | −5.1% | +80.4% |
| 6 months | +10.3% | +335.2% |
| Year to date | +69.8% | +429.3% |
| 1 year | +87.9% | +584.8% |
| Revenue growth (YoY) | — | +65.7% |
| Gross margin | −239.2% | 56.1% |
| Net margin | −6832.8% | −47.6% |
| P/E (TTM) | — | — |
| Price / sales | 1,003.7× | 20.1× |
| Net cash | $1.03B | $297.7M |
| Dividend yield | — | — |
| Volatility (60d) | 46.5% | 119.4% |
| Short % of float | 16.4% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).